Drug Shortage Report for CATHFLO
Report ID | 247639 |
Drug Identification Number | 02245859 |
Brand name | CATHFLO |
Common or Proper name | ALTEPLASE |
Company Name | HOFFMANN-LA ROCHE LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ALTEPLASE |
Strength(s) | 2MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INSTILLATION INSTILLATION |
Packaging size | 2MG VIAL, PACK OF 10 VIALS |
ATC code | B01AD |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2025-03-03 |
Actual start date | |
Estimated end date | 2025-04-16 |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2025-01-30 |
Company comments | A supply allocation of Cathflo is now in effect due to administrative site changes. We are currently working to resolve these issues so that we can resume normal supply distribution as soon as possible. If you require urgent assistance regarding Cathflo supply please contact Order and Distribution Management: mississauga.order_mgmt@roche.com or through the CPDN portal. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7070 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 5M8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2025-01-30 | French | Compare |
v5 | 2025-01-30 | English | Compare |
v4 | 2025-01-13 | French | Compare |
v3 | 2025-01-13 | French | Compare |
v2 | 2025-01-13 | English | Compare |
v1 | 2025-01-13 | English | Compare |
Showing 1 to 6 of 6